Aligned Genetics, Inc. (KOSDAQ:238120)

South Korea · Delayed Price · Currency is KRW

3,035.00

-90.00 (-2.88%)

At close: Aug 18, 2026

Aligned Genetics Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	15,735	16,016	15,778	15,215	13,753	11,762
Revenue Growth	-4.69%	1.51%	3.70%	10.63%	16.92%	47.82%
Gross Profit	11,351	11,221	11,148	10,659	8,755	7,338
Operating Income	2,142	2,443	2,780	3,337	2,849	2,179
Net Income	2,775	2,911	4,128	3,236	2,333	5,542
Earnings Per Share	197.09	206.24	287.00	225.00	162.00	385.40
EPS Growth	-30.20%	-28.14%	27.56%	38.89%	-57.97%	756.45%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	14,670	14,618	17,639	14,927	13,696	13,137
Total Debt	15,028	14,505	2,964	4,663	4,379	4,436
Net Cash (Debt)	-358.04	113.01	14,676	10,264	9,317	8,701
Net Cash Growth	-	-99.23%	42.98%	10.17%	7.07%	-20.97%
Net Cash Per Share	-25.43	8.01	1020.31	713.81	647.93	605.15

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3,279	3,605	3,065	2,849	2,222	135.97
Capital Expenditures	-10,977	-11,065	-257.69	-878.54	-2,001	-3,307
Free Cash Flow	-7,698	-7,459	2,808	1,970	220.98	-3,171
Free Cash Flow Growth	-	-	42.52%	791.50%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	72.14%	70.06%	70.66%	70.06%	63.66%	62.38%
Operating Margin	13.61%	15.25%	17.62%	21.93%	20.72%	18.52%
Pretax Margin	14.15%	16.54%	28.79%	22.51%	17.76%	32.41%
Profit Margin	17.64%	18.18%	26.16%	21.27%	16.96%	47.12%
FCF Margin	-48.92%	-46.58%	17.79%	12.95%	1.61%	-26.96%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	15.40	18.69	10.54	17.91	23.21	11.12
P/FCF Ratio	-	-	15.49	29.41	244.98	-
PS Ratio	2.74	3.40	2.76	3.81	3.94	5.24